CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 3.29: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.22%
Annual Rate
CNY 0.02Paid annual
Payout Ratio
420.0%High
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.46BCNY811.47M · vs all stocks (USD)
Trailing P/E
197.20xvs Medical Devices peers
Revenue (TTM)
1.79BCNY266.29M · vs all stocks (USD)
Profit Margin
1.74%vs Medical Devices peers
Beta
0.1910xvs all stocks
52-Week Change
-38.82%vs all stocks
Market Capitalization
5.46BCNY811.47M · vs all stocks (USD)
Enterprise Value
5.90BCNY877.53M · vs all stocks (USD)
Trailing P/E
197.20xvs Medical Devices peers
Forward P/E
19.62xvs Medical Devices peers
Price to Sales (TTM)
3.15xvs Medical Devices peers
Price to Book (MRQ)
2.08xvs Medical Devices peers
Enterprise to Revenue
3.29xvs Medical Devices peers
Enterprise to EBITDA
12.45xvs Medical Devices peers
Gross Margin
62.29%vs Medical Devices peers
Profit Margin
1.74%vs Medical Devices peers
Operating Margin
10.90%vs Medical Devices peers
Return on Assets (TTM)
2.60%vs Medical Devices peers
Return on Equity (TTM)
2.78%vs Medical Devices peers
Revenue (TTM)
1.79BCNY266.29M · vs all stocks (USD)
Revenue per Share (TTM)
2.95CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-4.80%vs Medical Devices peers
Gross Profit (TTM)
1.15BCNY170.90M · vs all stocks (USD)
EBITDA (TTM)
153.78MCNY22.87M · vs all stocks (USD)
Net Income (TTM)
31.14MCNY4.63M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
76.90%vs Medical Devices peers
Operating Cash Flow (TTM)
506.11MCNY75.26M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-55.85MCNY-8.31M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0210CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.22%vs all stocks
Payout Ratio
420.00%vs Medical Devices peers
Minority Interest (Equity)
-9.96MCNYFY2025 · Dec 31, 2025Revenue
1.81BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
636.56MCNYFY2025 · Dec 31, 2025Gross Profit
1.17BCNYFY2025 · Dec 31, 2025Operating Income
231.57MCNY34.44M · vs all stocks (USD)
Pre-tax Income
94.47MCNYFY2025 · Dec 31, 2025Income Tax Expense
26.14MCNYFY2025 · Dec 31, 2025Net Income
68.34MCNYFY2025 · Dec 31, 2025EBIT
117.36MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
491.93MCNYFY2025 · Dec 31, 2025Research & Development
304.92MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
148.92MCNYFY2025 · Dec 31, 2025Other Operating Expenses
22.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
22.89MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
583.52MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
583.52MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
68.34MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-45.00MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
103.28MCNYFY2025 · Dec 31, 2025Free Cash Flow
-255.90MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
379.30MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
68.34MCNYFY2025 · Dec 31, 2025Other Non-cash Items
31.23MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-79.39MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
83.10MCNYFY2025 · Dec 31, 2025Capital Expenditures
-359.18MCNYFY2025 · Dec 31, 2025Net Acquisitions
728.73KCNYFY2025 · Dec 31, 2025Purchase of Investments
-410.06MCNYFY2025 · Dec 31, 2025Sale of Investments
417.95MCNYFY2025 · Dec 31, 2025Other Investing Activity
16.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-334.55MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
868.57MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-871.62MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-141.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
-6.10MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-150.72MCNYFY2025 · Dec 31, 2025Shares Outstanding
571.39MSharesUpdated Aug 21, 2026Float Shares
342.85MSharesUpdated Aug 21, 2026% Held by Insiders
51.13%vs all stocks
% Held by Institutions
13.10%vs all stocks
Total Cash (MRQ)
661.96MCNY98.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.16CNYUpdated Aug 21, 2026Total Debt (MRQ)
939.20MCNY139.67M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3475xvs Medical Devices peers
Current Ratio (MRQ)
2.19xvs Medical Devices peers
Book Value per Share (MRQ)
4.75CNYUpdated Aug 21, 2026Total Assets
4.29BCNY637.78M · vs all stocks (USD)
Total Current Assets
1.97BCNYFY2025 · Dec 31, 2025Total Liabilities
1.60BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.32BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
677.13MCNYFY2025 · Dec 31, 2025Total Current Liabilities
924.27MCNYFY2025 · Dec 31, 2025Cash
379.31MCNYFY2025 · Dec 31, 2025Cash Equivalents
27.94MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
407.25MCNYFY2025 · Dec 31, 2025Other Short-term Investments
116.23MCNYFY2025 · Dec 31, 2025Accounts Receivable
584.09MCNYFY2025 · Dec 31, 2025Inventory
601.97MCNYFY2025 · Dec 31, 2025Accounts Payable
210.63MCNYFY2025 · Dec 31, 2025Short-term Debt
308.02MCNYFY2025 · Dec 31, 2025Other Current Liabilities
17.88MCNYFY2025 · Dec 31, 2025Long-term Debt
587.89MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.28MCNYFY2025 · Dec 31, 2025Common Stock (Book)
571.39MCNYFY2025 · Dec 31, 2025Retained Earnings
1.36BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.69BCNY399.63M · vs all stocks (USD)
52-Week Low
8.34CNYUpdated Aug 21, 202652-Week High
17.00CNYUpdated Aug 21, 202652-Week Change
-38.82%vs all stocks
Beta
0.1910xvs all stocks
50-Day MA
9.22CNYUpdated Aug 21, 2026200-Day MA
12.83CNYUpdated Aug 21, 2026Avg 10-Day Volume
14.60MSharesUpdated Aug 21, 2026Avg 30-Day Volume
10.37MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.0500CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.62Profit Margin: 0.02
Financial Health
Altman Z-Score 3.29: safe zoneNotable
Altman Z-Score: 3.29
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Konruns Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chengda Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Bioventus Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Anglikang Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Esperion Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Center Laboratories, Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanxi Zhendong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jacobio Pharmaceuticals Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beijing Chunlizhengda Medical Instruments Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
HK inno.N Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Medy-Tox Inc.
1 interpretationClose Below 40W SMA With Profitability
Aptiv PLC
1 interpretationClose Below 40W SMA With Profitability
Embecta Corp.
1 interpretationClose Below 40W SMA With Profitability